INnovative Diagnostic Imaging Capabilities Adoption To End-users delivers innovative imaging technology to your doorstep.
Micron is contributing to healthcare as a whole by approaching it from both diagnostic and therapeutic aspects.
We adopt, introduce, and propose image analysis technologies with advanced technology, such as those equipped with artificial intelligence (AI).
We act as a bridge between companies that want to introduce innovative software as medical device (SaMD) and companies which are interested in them.
Seeds – The introduction of diagnostic technologies (those under consideration for introduction in Japan)
Introducing new and unique diagnostic technologies. We assist in matching interested pharmaceutical companies and medical device manufacturers with companies which have these technologies.
|Note||Information updated on:|
|Brain tumor||Brain metastases auto-contouring solution on MRI scans. The product is applicable to longitudinal study and clinical trials with consistent 2D/3D measurements and automatic tumor response assessment.||7-Oct-21|
|Diabetic Retinopathy (DR)||AI-based analysis of color fundus photos (images of the retina)||23-Aug-21|
|All respiratory diseases and respiratory-related complications for other diseases||Functional Respiratory Imaging (FRI) – a set of distinct structural and functional imaging markers analysing drug exposure, structure and function of the lungs, pulmonary blood vessels and airways at the regional level via CT scans.||23-Aug-21|
|Epilepsy||Automated spike and seizure analysis, source localization on EEG in clinical practice. EEG biomarker research for clinical trials.||9-Jul-21|
|Sleep||Automated sleep staging and spindle analysis in clinical practice. EEG biomarker research for clinical trials.||9-Jul-21|
|Acute ischemic stroke||Perfusion brain image analysis (CT or MRI)||16-Jun-21|
|Multiple sclerosis (MS), Dementia, Traumatic brain injury (TBI), Epilepsy||Functional brain image analysis (CT or MRI)||16-Jun-21|
|Metabolic diseases, Musculoskeletal & neuromuscular disorders||Body composition analysis, delivering multiple fat and muscle biomarkers with unrivaled accuracy – all from a rapid whole-body MRI scan.||16-Jun-21|
|Carotid artery plaque||MRI image analysis||16-Jun-21|
|Central nervous system diseases||MRI image analysis||16-Jun-21|
Needs – The following diagnostic technologies are seeking new drug development and new medical device development.
These are the diagnostic technologies that companies developing new drugs and medical devices are looking for. We are looking forward to hearing from program medical device development companies with applicable diagnostic technologies.
Wanted Diagnostic Technologies
Information updated on:
|Radiation exposure||Dosimetry analysis for radionuclide therapy (PET)||16-Jun-21|
|Alzheimer’s disease||Auto SUVR measurement for efficacy assessment (PET)||16-Jun-21|
|Pulmonary||Automatic texture analysis software for pneumonia severity evaluation||16-Jun-21|
|Cardiac failure||Automatic heart function measurement software for efficacy assessment||16-Jun-21|
|Ischemic cardiac disease||Automatic vascular property (plaque deposition) analysis software for diagnosis support||16-Jun-21|
|Knee osteoarthritis||Cartilage quantitative analysis (MRI) for regenerative medicine treatment||16-Jun-21|
|Nail tinea||Automatic analysis of the affected area (Photo)||16-Jun-21|
|NAFLD, Malignant lymphoma||AI for automatic volume measurement of liver, spleen, etc.||16-Jun-21|
|COPD||Automatic measurement of %LAA, bronchial lumen, bronchial wall thickness, etc.||16-Jun-21|